| abstract |
An improved method for treating or curing ATL, with lowered side effects, comprising administering an effective amount of interferon-γ to a mammalian species in need of such treatment via respiratory tract by inhalation, wherein recommended is that a single dose of said interferon-γ to human adults is 1,000,000 JRU to 6,000,000 JRU and the single dose is repeated at a frequency between once-a-week and twice-a-day. |